Effects of Shenfu Injection in the Treatment of Septic Shock Patients: A Multicenter, Controlled, Randomized, Open-Label Trial

Table 4

Comparison of survival between the two groups.

	Shenfu (%)	Controls (%)	value
7 d
All patients mortality
Alive	81 (82.7)	76 (82.6)	0.994
Dead	17 (17.3)	16 (17.4)
Total (lost)	98 (4)	92 (5)
Mortality of patients with arterial lactate ≥4.5 mmol/L
Alive	20 (83.3)	12 (54.5)	0.034
Dead	4 (16.7)	10 (45.5)
Total (lost)	24 (2)	22 (3)
Mortality of patients with arterial lactate <4.5 mmol/L
Alive	61 (82.4)	64 (91.4)	0.111
Dead	13 (17.6)	6 (8.6)
Total (lost)	74 (2)	70 (2)
28 d
All patients mortality
Alive	59 (72.0)	58 (69.9)	0.770
Dead	23 (28.0)	25 (30.1)
Total (lost)	82 (20)	83 (14)
Mortality of patients with arterial lactate ≥4.5 mmol/L
Alive	16 (72.7)	10 (47.6)	0.092
Dead	6 (27.3)	11 (52.4)
Total (lost)	22 (4)	21 (4)
Mortality of patients with arterial lactate <4.5 mmol/L
Alive	43 (71.7)	48 (77.4)	0.466
Dead	17 (28.3)	14 (22.6)
Total (lost)	60 (16)	62 (10)